PANCREATIC NEUROENDOCRINE TUMOR
Clinical trials for PANCREATIC NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for PANCREATIC NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail offers hope for rare tumor patients
Disease control OngoingThis study tests whether combining two immunotherapy drugs, atezolizumab and bevacizumab, can shrink or control rare solid tumors that are hard to treat. About 133 adults with cancers like rare appendix, anal, cervical, penile, vulvar, neuroendocrine, Merkel cell, nasopharyngeal,…
Matched conditions: PANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:26 UTC
-
New hope for Hard-to-Treat gut tumors: drug blocks cancer growth
Disease control OngoingThis study tests the drug abemaciclib in 20 people with advanced digestive neuroendocrine tumors that have spread, stopped responding to standard treatment, and cannot be removed by surgery. The drug works by blocking enzymes that help cancer cells grow. The goal is to see if it …
Matched conditions: PANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 26, 2026 03:05 UTC
-
New pill shows promise for rare cancers in early trial
Disease control OngoingThis study tests an experimental oral drug called CVM-1118 in 34 people with advanced neuroendocrine tumors that have not responded to standard treatments. The goal is to see if the drug can slow tumor growth or shrink tumors. Participants take the drug by mouth and are monitored…
Matched conditions: PANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: TaiRx, Inc. • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New biopsy test may predict pancreatic tumor aggressiveness
Knowledge-focused OngoingThis study involves 100 adults with non-functional pancreatic neuroendocrine tumors. Researchers want to see if checking for two proteins, ATRX and DAXX, in biopsy samples can help predict how aggressive the tumor is. The goal is to improve current methods and better guide treatm…
Matched conditions: PANCREATIC NEUROENDOCRINE TUMOR
Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Knowledge-focused
Last updated May 26, 2026 02:48 UTC